CompuGroup Medical SE & Co. KGaA (HAM:COP)
Germany
· Delayed Price · Currency is EUR | Market Cap | 1.40B |
| Revenue (ttm) | 1.25B |
| Net Income (ttm) | 28.24M |
| Shares Out | 51.73M |
| EPS (ttm) | 0.54 |
| PE Ratio | 50.09 |
| Forward PE | n/a |
| Dividend | 0.50 (1.85%) |
| Ex-Dividend Date | Apr 20, 2026 |
| Volume | 350 |
| Average Volume | 568 |
| Open | 27.05 |
| Previous Close | 27.05 |
| Day's Range | 27.05 - 27.10 |
| 52-Week Range | 21.86 - 27.90 |
| Beta | 0.79 |
| RSI | 51.63 |
| Earnings Date | May 4, 2026 |
About HAM:COP
CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks. This segment also offers solutions that cover all essential clinical, administrative, and billing functions... [Read more]
Financial Performance
In 2025, HAM:COP's revenue was 1.25 billion, an increase of 5.10% compared to the previous year's 1.19 billion. Earnings were 28.24 million, a decrease of -18.37%.
Financial StatementsNews
EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the o...
EQS-News: Delisting of CompuGroup Medical to become effective as of 24 June 2025
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Delisting Delisting of CompuGroup Medical to become effective as of 24 June 2025 19.06.2025 / 11:21 CET/CEST The issuer is solely responsible ...
EQS-News: CompuGroup Medical issues joint reasoned statement recommending shareholders to accept CVC’s public delisting offer
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Delisting CompuGroup Medical issues joint reasoned statement recommending shareholders to accept CVC’s public delisting offer 06.06.2025 / 14:...
EQS-News: CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Delisting CompuGroup Medical and CVC plan delisting – public delisting offer announced by CVC 08.05.2025 / 22:09 CET/CEST The issuer is solely...
EQS-WpÜG: Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: Caesar BidCo GmbH
EQS-WpÜG: Caesar BidCo GmbH / Tender Offer Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: Caesar BidCo GmbH 08.05.2025 / 22:05 CET/CEST Dissemination of an announcement accor...
CompuGroup Medical SE & Co. KGaA Earnings Call Transcript: Q1 2025
Q1 2025 saw modest revenue growth of 1% year over year, driven by recurring revenues, while one-time revenues declined. Adjusted EBITDA and EPS fell, but free cash flow improved significantly. Strategic partnership with CVC Capital Partners was finalized, and full-year guidance for low to mid-single-digit organic growth was confirmed.
EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the o...
Q1/2025: CompuGroup Medical Faces a Slow Start
CompuGroup Medical started 2025 with a slight revenue increase, a strategic financial boost, and a strong focus on innovation, setting the stage for a promising year ahead. Jetzt den vollständigen Art...
EQS-News: Q1/2025: CompuGroup Medical reports slow start into the year
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Quarterly / Interim Statement/Quarter Results Q1/2025: CompuGroup Medical reports slow start into the year 30.04.2025 / 07:39 CET/CEST The iss...
EQS-News: Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes effect upon completion of the offer
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer Final regulatory approval for voluntary public takeover offer – Strategic partnership between CVC and CompuGroup Medical takes ef...
EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the o...
CompuGroup Medical SE & Co. KGaA Earnings Call Transcript: Q4 2024
2024 saw a 2% organic revenue decline, but recurring revenues grew 5% to nearly 75% of total, with adjusted EBITDA at €225 million and free cash flow at €66 million. Strategic acquisitions and a new partnership with CVC set the stage for renewed growth in 2025.
CompuGroup Medical: FY 2024 Results Align, Growth Expected in 2025
CompuGroup Medical SE & Co. KGaA faced a revenue dip in 2024 but saw a rise in recurring revenues, underscoring stability. With a focus on AI and innovation, the company eyes growth in 2025. Jetzt den...
CompuGroup Medical Slashes 2024 Dividend to Legal Minimum!
CompuGroup Medical SE & Co. KGaA is steering its financial course towards innovation, opting to slash its 2024 dividend to a mere EUR 0.05 per share, a stark drop from last year's EUR 1.00. Jetzt den ...
EQS-Adhoc: Ad-hoc: CompuGroup Medical SE & Co. KGaA intends to reduce the annual dividend for the financial year 2024 to the legal minimum
EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Dividend Ad-hoc: CompuGroup Medical SE & Co. KGaA intends to reduce the annual dividend for the financial year 2024 to the legal minimum 04-...
EQS-News: Final results of voluntary public takeover offer – CVC has secured 21.85% of total share capital and voting rights of CompuGroup Medical
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer Final results of voluntary public takeover offer – CVC has secured 21.85% of total share capital and voting rights of CompuGroup ...
EQS-News: Successful conclusion of initial acceptance period of CVC offer for CompuGroup Medical – Additional acceptance period from 29 January to 11 February 2025
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous Successful conclusion of initial acceptance period of CVC offer for CompuGroup Medical – Additional acceptance period from 29 Ja...
EQS-News: CVC exceeds minimum acceptance threshold for voluntary public tender offer for CompuGroup Medical – additional acceptance period expected to commence on 29 January
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer CVC exceeds minimum acceptance threshold for voluntary public tender offer for CompuGroup Medical – additional acceptance period ...
EQS-News: CGM issues joint reasoned statement recommending that shareholders accept CVC's voluntary public takeover offer
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous CGM issues joint reasoned statement recommending that shareholders accept CVC's voluntary public takeover offer 03.01.2025 / 11:...
CompuGroup Medical SE & Co. KGaA Transcript: Investor Update
An investment agreement with CVC Capital Partners includes a €22 per share tender offer, a 51% premium, aiming to take the company private while the founding family retains majority control. The offer is subject to regulatory approvals and a 17% minimum acceptance threshold.
EQS-News: CompuGroup Medical enters into an investment agreement with CVC Capital Partners
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous CompuGroup Medical enters into an investment agreement with CVC Capital Partners 09.12.2024 / 09:19 CET/CEST The issuer is solel...
EQS-WpÜG: Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: SCUR-Alpha 269 GmbH (in future: Caesar BidCo GmbH)
EQS-WpÜG: SCUR-Alpha 269 GmbH (künftig: Caesar BidCo GmbH) / Tender Offer Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: SCUR-Alpha 269 GmbH (in future: Caesar BidCo GmbH) 09...
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA: CVC announces a voluntary public tender offer based on an investment agreement concluded with CompuGroup Medical SE & Co. KGaA
EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer CompuGroup Medical SE & Co. KGaA: CVC announces a voluntary public tender offer based on an investment agreement concluded with...
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC
EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC 08-Dec-2024 / 23:01 CET/CEST ...
CVC In Talks to Take German Software Firm CompuGroup Private
CVC Capital Partners Plc is exploring an acquisition of CompuGroup Medical SE & Co. KGaA, a German software provider to the healthcare sector, according to people familiar with the matter.